<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03166982</url>
  </required_header>
  <id_info>
    <org_study_id>CHU-0283</org_study_id>
    <secondary_id>2016-A00961-50</secondary_id>
    <nct_id>NCT03166982</nct_id>
  </id_info>
  <brief_title>Drainage of Tubo - Ovarian Abscess: DTOA</brief_title>
  <acronym>DTOA</acronym>
  <official_title>Comparative Effectiveness Clinical Early of Transvaginal and Laparoscopic Approaches for Drainage of Tubo -Ovarian Abscess. Randomized Noninferiority</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The treatment of the acute phase of the complicated abscess tubo-ovarian relies on
      antibiotics more or less associated with surgical management in case of visible abscess, poor
      clinical tolerance (sepsis) and resistance to medical treatment. The CNGOF recommended in
      2012 that the tubo-ovarian abscess are not within one antibiotic, and should be drained by
      interventional radiology, preferably by transvaginal or laparoscopic.

      Furthermore the efficiency of drainage by ultrasound puncture performed vaginally was
      demonstrated. This approach tends to replace the first laparoscopy because of its less
      invasive, fast, easy to access, more acceptable and less cost compared to laparoscopy. This
      approach is recommended by the French and English colleges.

      In total, the surgery in case of ATO is necessary, it is always coupled with antibiotics.
      Several surgical approaches are possible, laparotomy, laparoscopy and ultrasound-guided
      puncture. No prospective comparative study has been done, for which we want to develop this
      study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Retrospective studies evaluating the efficacy of these two supported relate the same cure
      rates between the two techniques. According to the literature of Garbin O.and al in 2012, the
      success rate of transvaginal puncture is generally 93.6%. The largest series of Gjelland al
      in 2005 and covers 302 consecutive patients with ATO who underwent triple antibiotic therapy
      and transvaginal puncture, the success rate was 93.4%. The failures that required surgical
      management have frequently revealed endometriosis or cancer. To support laparoscopic, Raiga
      and al in 1996 studied the support of 36 retrospectively patients who underwent laparoscopic
      incisional and wash the abscess with a success rate of 100%. Moreover Reich and al in 1987
      found 90% success on a review of 25 patients.

      The transvaginal echo guided puncture to replace the first laparoscopy because of its less
      invasive nature, this is a simple act, fast, possible under mild sedation, the cost is still
      lower than laparoscopy. Some uncontrolled retrospective studies suggest that laparoscopy
      remains associated with prolongation of hospitalization time, it is also mentioned that the
      transvaginal puncture is better tolerated by the patient.

      No study has compared these two techniques, which is why we propose this study.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 26, 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants receive an intervention throughout the protocol</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Open</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical cure rate defined by a composite score as defined by O'Brien PC (Procedures for Comparing samples with multiple endpoints Biometrics 1984; 40: 1079-1087.)</measure>
    <time_frame>at 72 hour</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical cure rate defined by a composite score as defined by O'Brien PC (Procedures for Comparing samples with multiple endpoints Biometrics 1984; 40: 1079-1087.)</measure>
    <time_frame>at 1 month</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Clinical improvement</measure>
    <time_frame>at 72 hours and at 1 month</time_frame>
    <description>apyrexia to 72 hours and 1 month and EVA to 72 hours and 1 month</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Organic improvement</measure>
    <time_frame>at 72 hours and at 1 month</time_frame>
    <description>CRP Standards and GB to 72 hours and 1 month if initially high</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of hospital stay</measure>
    <time_frame>at day 0</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analgesia Type: general anesthesia versus sedation</measure>
    <time_frame>at day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>recurrent complications</measure>
    <time_frame>at day 1</time_frame>
    <description>Per Statement of complications and postoperative and rehospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operating Time</measure>
    <time_frame>at day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fertility prognosis by Mage score</measure>
    <time_frame>at 3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>prognosis of chronic pelvic pain score by adhesions at second look laparoscopy</measure>
    <time_frame>at 3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Tubo-ovarian Abscess</condition>
  <arm_group>
    <arm_group_label>laparoscopy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the tubo-ovarian abscess should be drained by interventional radiology, preferably by transvaginal or laparoscopic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ultrasound-guided puncture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The transvaginal echo guided puncture to replace the first laparoscopy because of its less invasive nature, this is a simple act, fast, possible under mild sedation, the cost is still lower than laparoscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>transvaginal approach</intervention_name>
    <arm_group_label>ultrasound-guided puncture</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>laparoscopic approach</intervention_name>
    <arm_group_label>laparoscopy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with a IGH with tubo-ovarian abscess visible on ultrasound or CT

          -  Ultrasound abscess&gt; or equal to 2cm

          -  Abdominal pain syndrome

          -  Age 18 to 43 years

          -  understand french language

          -  No complicated: good hemodynamic tolerance, not broken

          -  These patients should be affiliated to the French Social Security and must have given
             informed participation agreement

        Exclusion Criteria:

        Patients with HIV (CD4 &lt;200) or co-infections: immunosuppression

          -  Multi-Abdomen surgery

          -  Suspected malignant or borderline tumor

          -  Complicated abscess: rupture of the abscess, peritonitis, septic shock

          -  Postoperative pelvic abscess

          -  Patient minor

          -  During Pregnancy

          -  Patient having already been accounted for tubo-ovarian abscess in progress

          -  Not accessible abscess transvaginal puncture

          -  Patients unable major, patients suffering from mental pathology incompatible with
             informed consent, refusal to participate
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>43 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne-Sophie GREMEAU</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Clermont-Ferrand</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patrick LACARIN</last_name>
    <phone>04 73 75 15 95</phone>
    <email>placarin@chu-clermontferrand.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick LACARIN</last_name>
      <phone>04 73 75 11 95</phone>
      <email>placarin@chu-clermontferrand.fr</email>
    </contact>
    <investigator>
      <last_name>Michel CANIS, PUPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Luc POULY, PUPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Benoit RABISCHONG, PUPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicolas BOURDEL, PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandra CURINIER, PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Martine BONIN, PH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Candice CHAUFFOUR, CCA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adrien TRAN MAU THEM, CCA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicolas AGAR, CCA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Gjelland K, Ekerhovd E, Granberg S. Transvaginal ultrasound-guided aspiration for treatment of tubo-ovarian abscess: a study of 302 cases. Am J Obstet Gynecol. 2005 Oct;193(4):1323-30.</citation>
    <PMID>16202721</PMID>
  </reference>
  <reference>
    <citation>Granberg S, Gjelland K, Ekerhovd E. The management of pelvic abscess. Best Pract Res Clin Obstet Gynaecol. 2009 Oct;23(5):667-78. doi: 10.1016/j.bpobgyn.2009.01.010. Epub 2009 Feb 20. Review.</citation>
    <PMID>19230781</PMID>
  </reference>
  <reference>
    <citation>Gerber B, Krause A. A study of second-look laparoscopy after acute salpingitis. Arch Gynecol Obstet. 1996;258(4):193-200.</citation>
    <PMID>8844136</PMID>
  </reference>
  <reference>
    <citation>Le Bouëdec G, Pouly JL, Canis M, Wattiez A, Abbas B, Mage G, Bruhat MA. [Acute salpingitis. Celioscopy before and after treatment: 110 cases]. J Gynecol Obstet Biol Reprod (Paris). 1991;20(5):680-4. French.</citation>
    <PMID>1835469</PMID>
  </reference>
  <reference>
    <citation>Raiga J, Canis M, Le Bouëdec G, Glowaczower E, Pouly JL, Mage G, Bruhat MA. Laparoscopic management of adnexal abscesses: consequences for fertility. Fertil Steril. 1996 Nov;66(5):712-7.</citation>
    <PMID>8893672</PMID>
  </reference>
  <reference>
    <citation>Heinonen PK, Leinonen M. Fecundity and morbidity following acute pelvic inflammatory disease treated with doxycycline and metronidazole. Arch Gynecol Obstet. 2003 Oct;268(4):284-8. Epub 2002 Oct 26.</citation>
    <PMID>14504870</PMID>
  </reference>
  <reference>
    <citation>Trent M, Bass D, Ness RB, Haggerty C. Recurrent PID, subsequent STI, and reproductive health outcomes: findings from the PID evaluation and clinical health (PEACH) study. Sex Transm Dis. 2011 Sep;38(9):879-81. doi: 10.1097/OLQ.0b013e31821f918c.</citation>
    <PMID>21844746</PMID>
  </reference>
  <reference>
    <citation>Ness RB, Soper DE, Holley RL, Peipert J, Randall H, Sweet RL, Sondheimer SJ, Hendrix SL, Amortegui A, Trucco G, Songer T, Lave JR, Hillier SL, Bass DC, Kelsey SF. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. Am J Obstet Gynecol. 2002 May;186(5):929-37.</citation>
    <PMID>12015517</PMID>
  </reference>
  <reference>
    <citation>Abbitt PL, Goldwag S, Urbanski S. Endovaginal sonography for guidance in draining pelvic fluid collections. AJR Am J Roentgenol. 1990 Apr;154(4):849-50.</citation>
    <PMID>2107687</PMID>
  </reference>
  <reference>
    <citation>Buchweitz O, Malik E, Kressin P, Meyhoefer-Malik A, Diedrich K. Laparoscopic management of tubo-ovarian abscesses: retrospective analysis of 60 cases. Surg Endosc. 2000 Oct;14(10):948-50.</citation>
    <PMID>11080409</PMID>
  </reference>
  <reference>
    <citation>Henry-Suchet J, Soler A, Loffredo V. Laparoscopic treatment of tuboovarian abscesses. J Reprod Med. 1984 Aug;29(8):579-82.</citation>
    <PMID>6237196</PMID>
  </reference>
  <reference>
    <citation>Garbin O, Verdon R, Fauconnier A. [Treatment of the tubo-ovarian abscesses]. J Gynecol Obstet Biol Reprod (Paris). 2012 Dec;41(8):875-85. doi: 10.1016/j.jgyn.2012.09.012. Epub 2012 Nov 10. Review. French.</citation>
    <PMID>23146745</PMID>
  </reference>
  <reference>
    <citation>Perez-Medina T, Huertas MA, Bajo JM. Early ultrasound-guided transvaginal drainage of tubo-ovarian abscesses: a randomized study. Ultrasound Obstet Gynecol. 1996 Jun;7(6):435-8.</citation>
    <PMID>8807761</PMID>
  </reference>
  <reference>
    <citation>Vermersch C, Dessein R, Lucot JP, Rubod C, Cosson M, Giraudet G. [Tubo-ovarian abscesses treatment: Faisability and results of trans-vaginal ultrasound-guided aspiration]. J Gynecol Obstet Biol Reprod (Paris). 2016 Mar;45(3):243-8. doi: 10.1016/j.jgyn.2015.04.016. Epub 2015 Jun 19. French.</citation>
    <PMID>26096351</PMID>
  </reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 10, 2016</study_first_submitted>
  <study_first_submitted_qc>May 23, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 25, 2017</study_first_posted>
  <last_update_submitted>May 23, 2017</last_update_submitted>
  <last_update_submitted_qc>May 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Tubo-ovarian abscess</keyword>
  <keyword>Transvaginal drainage</keyword>
  <keyword>Laparoscopic treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Abscess</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

